Interleukin-24,IL-24,Melanoma differentiation-associated gene 7 protein,MDA-7,Suppression of tumorigenicity 16 protein,IL24,MDA7,ST16
Drug Development Progress
Drugs in Clinical Trials1
Approved Drugs0
Highest Development StagePhase 1 Clinical
Target Synonym
ST16,Interleukin-24,IL24,MDA-7,Suppression of tumorigenicity 16 protein,IL-24,Interleukin 24,Suppression Of Tumorigenicity 16 (Melanoma Differentiation),Melanoma Differentiation-Associated Gene 7 Protein,IL-4-Induced Secreted Protein,MDA7,Melanoma Differentiation Association Protein 7,Melanocyte-Associated Mda-7,IL10B,C49A,FISP,MOB5,Mob-5
Background
Interleukin-24 (IL-24, also known as melanoma differentiation-associated gene-7) belongs to the family of IL-10-related cytokines, which includes IL-10, -19, -20, -22, -24 and -26. Interleukin 24 signals through two heterodimeric receptors: IL-20R1/IL-20R2 and IL-22R1/IL-20R2. Upon binding to its receptors, IL-24 induces rapid activation of Stat-1 and Stat-3 transcription factors, which appear to play a role in cell survival and proliferation . Structurally and functionally, IL-24 is highly conserved across species.IL-24 has been shown to possess cancer-specific apoptosis-inducing activity, and has therefore been suggested as a potential anti-cancer agent.
IL-24 Product List
No Data
You Have Viewed 0 Of 0 Results
1
No Data
No Data
Can’t find what you need?
Submit your requirements and our technical team will help.